已收盘 02-06 16:00:00 美东时间
-0.040
-0.16%
今日重点评级关注:HC Wainwright & Co.:维持Praxis Precision Medicine"买入"评级,目标价从340美元升至1245美元;HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从10美元升至12美元
02-02 14:15
Keefe, Bruyette & Woods analyst Timothy Switzer maintains Civista Bancshares (NASDAQ:CIVB) with a Outperform and raises the price target from $27 to $28.
01-30 23:12
Civista Bancshares (NASDAQ:CIVB) released its Q4 earnings on Thursday, January ...
01-29 21:26
Civista Bancshares (NASDAQ:CIVB) released its Q4 earnings on Thursday, January ...
01-29 21:10
Civista Bancshares (NASDAQ:CIVB) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.57 by 30.66 percent. This is a 19.05 percent increase over earnings of $0.63 per share from
01-29 21:09
Companies Reporting Before The Bell • MOGU (NYSE:MOGU) is estimated to report e...
01-29 19:11
今日重点评级关注:Canaccord Genuity:维持Fractyl Health"买入"评级,目标价从6美元升至8美元;HC Wainwright & Co.:维持MediWound"买入"评级,目标价从31美元升至36美元
2025-11-24 11:23
DA Davidson analyst Jeff Rulis maintains Civista Bancshares (NASDAQ:CIVB) with a Buy and maintains $26 price target.
2025-11-22 02:14
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
2025-10-28 10:08
今日重点评级关注:HC Wainwright & Co.:维持Alto Neuroscience"买入"评级,目标价从10美元升至50美元;RBC Capital:维持Precision Drilling"跑赢大市"评级,目标价从110美元升至117美元
2025-10-27 09:45